Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 6/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | NSD2 | O96028 | 1/20 | 0.51 |
| ▸ | TYR | P14679 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | SCN1A | P35498 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.50 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24871462 | 1.00 | SERPINE1 (0.67) | SERPINE1L3MBTL1MAPK1HIF1ANSD2 | |
| SCHEMBL23484199 | 0.91 | SERPINE1 (0.80) | SERPINE1L3MBTL1TYRTDP1ESR1 | |
| SCHEMBL2020359 | 0.87 | MAPK1 (0.71) | L3MBTL1MAPK1HIF1AHTR1ACYP2D6 | |
| SCHEMBL27407969 | 0.81 | MAPK1 (0.62) | L3MBTL1MAPK1HIF1AHTR1ACYP2D6 | |
| SCHEMBL7773961 | 0.80 | SERPINE1 (1.00) | SERPINE1L3MBTL1TYRTDP1ESR1 | |
| SCHEMBL18652189 | 0.80 | SERPINE1 (0.80) | SERPINE1L3MBTL1TYRTDP1ESR1 | |
| SCHEMBL6053597 | 0.79 | MAPK1 (0.65) | L3MBTL1MAPK1HIF1AHTR1ACYP2D6 | |
| SCHEMBL570797 | 0.79 | MAPK1 (0.65) | MAPK1HIF1AHTR1ACYP2D6SCN1A | |
| SCHEMBL6053888 | 0.79 | MAPK1 (0.65) | L3MBTL1MAPK1HIF1AHTR1ACYP2D6 | |
| SCHEMBL18725349 | 0.79 | ADRB2 (0.56) | L3MBTL1MAPK1HIF1AHTR1ACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250057802-A1 | BROAD-SPECTRUM ANTIVIRAL DRUGS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-02-20 | — | — | US | disclosed |
| WO-2023281063-A1 | BROAD-SPECTRUM ANTIVIRAL DRUGS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250057802-A1 | BROAD-SPECTRUM ANTIVIRAL DRUGS | MAVS, EIF2AK2, ZC3HAV1 | SERPINE1 1823/4885L3MBTL1 3121/4885MAPK1 4668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.